English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Myotonic dystrophy (dystrophia myotonica [DM]) is an autosomal-dominant, multi-systemic disease for which the clinical presentation includes myotonia, muscular dystrophy, cardiac involvement, posterior iridescent cataracts, and endocrine disorders.1 The incidence of myotonic dystrophy type 1 (DM1) has been estimated to be 1 case per 8000 births, and its worldwide prevalence ranges from 2.1 to 14.3 cases per 100 000 inhabitants.2 In patients with DM1, cardiac involvement (e.g., conduction abnormality and conduction blocks) is common; such involvement contributes significantly to DM1-related morbidity and mortality.3 However, only few cases of arrhythmic cardiac involvement with significant gastrointestinal abnormalities, especially in the esophagus, have been reported. Here, we describe a case of myotonic dystrophy and achalasia-like esophageal dilatation with atrial fibrillation (AF) treated with radiofrequency catheter ablation (RFCA). Myotonic dystrophy was confirmed by genetic testing. Case

Radiofrequency Catheter Ablation of Persistent Atrial Fibrillation with Myotonic Dystrophy and Achalasia-like Esophageal Dilatation